[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for postprandial glucose control in type 1 diabetes mellitus (T1DM). It automatically coordinates the values of basal-bolus insulin to be infused during the postprandial period so as to achieve some predefined control objectives. However, the method requires an excessive computation time to compute the solution set of feasible insulin profiles, which impedes its integration into an insulin pump. In this work, a new algorithm is presented, which reduces computation time significantly and enables the integration of this new bolus advisor into current processing features of smart insulin pumps. Methods: A new strategy was implemented that focu...
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabete...
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for...
"© 2011 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for ...
Background and Objective: Although there has been significant progress towards closed-loop type 1 di...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
BACKGROUND: People with insulin-dependent diabetes rely on an intensified insulin regimen. Despite s...
International audienceThere is room for improvement in the algorithms used in closed-loop insulin th...
Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancrea...
With discovery of the insulin, Type-1 diabetes converted from a fatal and acute to a chronic disease...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: In insulin pump therapy, optimization of bolus and basal insulin dose settings is a chal...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabete...
[EN] Objective: Set-inversion-based prandial insulin delivery is a new model-based bolus advisor for...
"© 2011 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for ...
Background and Objective: Although there has been significant progress towards closed-loop type 1 di...
In the daily management of type 1 diabetes (T1D), determining the correct insulin dose to be injecte...
BACKGROUND: People with insulin-dependent diabetes rely on an intensified insulin regimen. Despite s...
International audienceThere is room for improvement in the algorithms used in closed-loop insulin th...
Type 1 diabetes-mellitus implies a life-threatening absolute insulin deficiency. Artificial pancrea...
With discovery of the insulin, Type-1 diabetes converted from a fatal and acute to a chronic disease...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: In insulin pump therapy, optimization of bolus and basal insulin dose settings is a chal...
Background: Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-for...
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not ...
Type 1 diabetes mellitus (T1DM) is a chronic disease characterized by the body’s inability to produc...
Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabete...